ArticleFrontiers in pharmacology2014

Engaging novel cell types, protein targets and efficacy biomarkers in the treatment of diabetic nephropathy.

Ryan M Fryer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.